From: Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
Standard care (n = 12)
Interferon (n = 44)
LPV/r plus interferon (n = 67)
Total patients (n = 123)
P-value
Oxygen-support duration
13 (7, 24)
13 (8, 16)
11 (7, 22)
12 (8, 19)
0.98
Viral clearance
9 (5, 15)
11 (8, 17)
14 (8, 20)
12 (7, 18)
0.33